Share-based Payment Arrangement, Expense of ClearPoint Neuro, Inc. from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ClearPoint Neuro, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • ClearPoint Neuro, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,022,000, a 6.2% increase year-over-year.
  • ClearPoint Neuro, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $7,902,000, a 17% increase year-over-year.
  • ClearPoint Neuro, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6,907,000, a 14% increase from 2023.
  • ClearPoint Neuro, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6,079,000, a 47% increase from 2022.
  • ClearPoint Neuro, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4,126,000, a 99% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ClearPoint Neuro, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,902,000 $2,022,000 +$118,000 +6.2% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $7,784,000 $2,269,000 +$473,000 +26% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $7,311,000 $1,908,000 +$404,000 +27% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $6,907,000 $1,703,000 +$160,000 +10% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
Q3 2024 $6,747,000 $1,904,000 +$320,000 +20% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $6,427,000 $1,796,000 +$151,000 +9.2% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $6,276,000 $1,504,000 +$197,000 +15% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $6,079,000 $1,543,000 +$371,000 +32% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $5,708,000 $1,584,000 +$409,000 +35% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $5,299,000 $1,645,000 +$765,000 +87% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $4,534,000 $1,307,000 +$408,000 +45% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $4,126,000 $1,172,000 01 Oct 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $1,175,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $880,000 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $899,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2015 $367,309 +$187,563 +104% 01 Jan 2015 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q3 2014 $192,001 -$153,631 -44% 01 Jul 2014 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 $184,162 -$139,962 -43% 01 Apr 2014 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 $179,746 -$138,721 -44% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q3 2013 $345,632 +$45,328 +15% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $324,124 +$10,417 +3.3% 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014 2014 Q2
Q1 2013 $318,467 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1
Q3 2012 $300,304 +$51,764 +21% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q2 2012 $313,707 +$59,790 +24% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q3 2011 $248,540 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q3
Q2 2011 $253,917 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2

ClearPoint Neuro, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,907,000 +$828,000 +14% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
2023 $6,079,000 +$1,953,000 +47% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 $4,126,000 +$2,048,000 +99% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
2021 $2,078,000 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.